Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

MEDICLIN (MED) Price & Analysis

MED Stock Chart & Stats

€5.30-€0.05(-0.93%)
At close: 4:00 PM EDT
EUR 4EUR 4.5EUR 5EUR 5.53 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 5.25 - EUR 5.30
52-Week Range
EUR 3.22 - EUR 5.80
Previous Close
EUR 5.35
Volume
15.80K
Average Volume (3M)
6,026
Market Cap
EUR 251.75M
Enterprise Value
EUR 493.77M
Total Cash (Recent Filing)
EUR 77.39M
Total Debt (Recent Filing)
EUR 382.37M
Price to Earnings (P/E)
8.7
Beta
0.31
Next Earnings
Nov 05, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
0.75%

Bulls Say, Bears Say

Bulls Say

Revenue And Profitability Recovery

Improving revenue growth and a return to profitability indicate recovery in operating performance. Sustained demand across acute care, rehabilitation, and nursing services could support further earnings normalization over the next several quarters.

Consistently Positive Free Cash Flow

Reliable cash generation gives MEDICLIN funding for facility investment, service capacity, and debt repayment without relying entirely on external financing. Positive free cash flow also improves resilience in a regulated, capital-intensive healthcare model.

Balance Sheet Improvement

Although leverage remains high, the multiyear reduction in debt-to-equity and continued equity building show progress toward a stronger financial structure. This can gradually increase resilience and expand flexibility for reinvestment or debt reduction.

Bears Say

Elevated Leverage

Debt remains substantial relative to equity despite recent improvement. High leverage can constrain investment, increase sensitivity to financing costs, and reduce the company’s ability to absorb weaker occupancy, reimbursement pressure, or higher staffing expenses.

Modest Operating Margins

Thin margins leave limited room to absorb rising wages, energy costs, compliance spending, or unfavorable reimbursement changes. Even with improving profitability, MEDICLIN may need sustained utilization and cost control to convert revenue growth into durable earnings expansion.

Moderate Cash Conversion

Positive free cash flow is supportive, but only moderate conversion means accounting earnings do not fully translate into available cash. Ongoing working-capital needs and capital expenditure could limit debt reduction and reduce flexibility during operational or regulatory pressure.

MED FAQ

What was MEDICLIN’s price range in the past 12 months?
MEDICLIN lowest stock price was €3.22 and its highest was €5.80 in the past 12 months.
What is MEDICLIN’s market cap?
MEDICLIN’s market cap is €251.75M.
When is MEDICLIN’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MEDICLIN’s earnings last quarter?
MEDICLIN released its earnings results on Jul 30, 2026. The company reported €0.206 earnings per share for the quarter.
Is MEDICLIN overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does MEDICLIN pay dividends?
MEDICLIN pays a Annually dividend of €0.04 which represents an annual dividend yield of 0.75%. See more information on MEDICLIN dividends here
What is MEDICLIN’s EPS estimate?
MEDICLIN’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MEDICLIN have?
MEDICLIN has 47,500,000 shares outstanding.
What happened to MEDICLIN’s price movement after its last earnings report?
MEDICLIN reported an EPS of €0.206 in its last earnings report. Following the earnings report the stock price went down -0.966%.
Which hedge fund is a major shareholder of MEDICLIN?
Currently, no hedge funds are holding shares in DE:MED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology